DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Epicatechin is an investigational drug.
There have been 13 clinical trials for Epicatechin. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2007.
The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Prediabetic State. The leading clinical trial sponsors are Cardero Therapeutics, Inc., National Center for Complementary and Integrative Health (NCCIH), and Craig McDonald, MD.
Recent Clinical Trials for Epicatechin
|Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents||Cardero Therapeutics, Inc.||Phase 1/Phase 2|
|Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents||Craig McDonald, MD||Phase 1/Phase 2|
|(-)- Epicatechin Becker Muscular Dystrophy||Cardero Therapeutics, Inc.||Phase 2|